New Customer Contracts
RNS Number : 9343ZKRM22 PLC22 October 2026KRM22 plc
(“KRM22”, the “Group” or the “Company”)
New Customer Contracts
ARR for KRM22 plc up to £8.5m
KRM22 plc, (AIM: KRM) the technology and software investment company that focuses on risk management for capital markets, is pleased to announce the signing of two new customer contracts for the Risk Manager application.
The two new contracts each cover a period of three years with a combined value of US$1.3m over the life of the contracts. One contract is with an existing Futures Commission Merchant (“FCM”) customer who is already using the Limits Manager application, whilst the second contract is with a new customer.
Following these contract wins, the total value of the Company’s Annual Recurring Revenue (“ARR”) attributable to the Risk Manager application is £3.4m from 18 customers, of which four customers, with total ARR of £0.4m, are on the legacy At-Trade and Post-Trade contracts.
Separate to these new contracts, the Company has been notified of one contract termination for its Surveillance Manager application. The contract termination, with ARR of £0.2m, is a result of industry consolidation with the customer having been acquired in 2025 and the acquiring company benefiting from operational synergies.
Following the announcement of these two new contracts and the contract termination, and at current GBP:USD exchange rates, the Group’s ARR as at the date of this announcement has increased to £8.5m.
Dan Carter, CEO commented: “These new contract wins for Risk Manager demonstrate the continued demand for KRM22’s enhanced risk solutions. With ARR increasing to £8.5m, we remain focused on achieving our end-of-year target and continuing to build the sales pipeline to drive future growth.”
For further information please contact:
KRM22 plc
Dan Carter, CEO
Kim Suter, CFO
Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)
Stephen Keys / Isaac Hooper (Corporate Finance)
Sunila de Silva (ECM)
+44 (0)20 7220 0500
The information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended. With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.
About KRM22 plc
KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018. The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.
Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management. The Global Risk Platform provides applications to help address firms' trading and corporate risk challenges and to manage their entire enterprise risk profile.
Capital markets companies partner with KRM22 to optimise risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.
KRM22 plc is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.
See more about KRM22 at KRM22.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDCNTUAVSRNRURUAA
